Physician profile
Qi Wang
NPI 1326457847
$656.39
in general payments reported to CMS, 2019-2025
8 companies · $309 in 2025
The $309 reported for 2025 was more than what 84% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $150 · 2022: $16.48 · 2023: $82.91 · 2024: $98.25 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $232 · Travel and Lodging: $186 · Honoraria: $50.26 · Education: $21.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $232.23 |
| Travel and Lodging | $185.57 |
| Honoraria | $50.26 |
| Education | $21.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $308.75 | 2025 | Suresmile, Astra Tech Implant System |
| Straumann USA LLC | $150.00 | 2020 | |
| Benco Dental Supply Co. | $50.26 | 2024 | |
| Nobel Biocare USA | $47.01 | 2022-2023 | Nobelactive |
| Air Techniques, INC. | $34.34 | 2024 | Scan X Ortho |
| Kerr Corporation | $30.53 | 2023 | Nexus Rmgi |
| Colgate Oral Pharmaceuticals, INC. | $21.85 | 2023 | |
| Gc America INC. | $13.65 | 2024 | G-Aenial, G-Premio Bond, Equia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Qi Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.